首页> 外国专利> Kit (nonradioactive precursor) for the preparation of an enantiomeric form of the renal function diagnostic technetium-99m-mercaptoacetyltriglycine (99m-Tc-MAG-3) and method of making the kit

Kit (nonradioactive precursor) for the preparation of an enantiomeric form of the renal function diagnostic technetium-99m-mercaptoacetyltriglycine (99m-Tc-MAG-3) and method of making the kit

机译:用于制备对映体形式的肾功能诊断tech- 99m-巯基乙酰基三甘氨酸(99m-Tc-MAG-3)的试剂盒(非放射性前体)及其制备方法

摘要

The invention relates to an inactive composition (kit) for preparing a stable enantiomeric form of technetium-99m mercaptoacetyltriglycine (99mTc-MAG-3) for nuclear medical examinations of kidney function, and to a process for producing this kit. The kit according to the invention consists of two components which are packed separately and the first of which consists of a lyophilised mixture of mercaptoacetyltriglycine, of a coligand stabilising oxidation state +5 of Tc, of a reducing agent and alkali metal or alkaline earth metal hydroxide in the molar ratio 1 : (50 - 150) : (0.1 - 0.5) : (30 - 80 MAG-3 : coligand : reducing agent : hydroxide and whose second component contains a sterile phosphate buffer solution with an amount of acid corresponding to the molar ratio MAG-3 : hydroxide. Used for this purpose in a preferred embodiment is a salt of tartaric acid or gluconic acid, in particular Na2 tartrate, as coligand, SnCl2 as reducing agent, and NaOH as hydroxide. Concerning the process, the invention comprises, for the preparation of component 1 of the kit, hydrolysing benzoyl-MAG-3 with alcoholate in alcoholic solution and mixing the mercaptoacetyltriglycine ligand obtained in this way with the mercapto group in unprotected form with the reducing agent and with the coligand which stabilises oxidation state +5 of Tc at pH 11 in the ratio indicated above, lyophilising and packing in portions.
机译:本发明涉及用于制备用于肾功能的核医学检查的稳定的对映体形式的-99m巯基乙酰基三甘氨酸(<99m Tc-MAG-3)的无活性组合物(试剂盒),并且涉及该试剂盒的制备方法。根据本发明的试剂盒由分别包装的两个组分组成,其中的一个组分由巯基乙酰基三甘氨酸的冻干混合物组成,该巯基乙酰基三甘氨酸具有稳定的大分子Tc +5的大肠菌素,还原剂和碱金属或碱土金属氢氧化物摩尔比为1:(50-150):(0.1-0.5):(30-80> MAG-3:大分子配体:还原剂:氢氧化物,其第二成分包含无菌磷酸盐缓冲溶液,其酸含量为在一个优选的实施方案中,为此目的使用的是酒石酸或葡糖酸的盐,特别是酒石酸钠作为酒石配体的酒石酸钠,作为还原剂的SnCl2和作为氢氧化物的NaOH。为了制备试剂盒的组分1,本发明包括在醇溶液中用醇化物水解苯甲酰基-MAG-3,并将以此方式获得的巯基乙酰基三甘氨酸配体与未保护的巯基混合。用还原剂和大肠菌素以上述比例将Tc的氧化态+5稳定在pH> 11时形成冻干和分装。

著录项

  • 公开/公告号DE122005000028I2

    专利类型

  • 公开/公告日2007-08-16

    原文格式PDF

  • 申请/专利权人 ROTOP PHARMAKA AG DE;

    申请/专利号DE19901200028C

  • 发明设计人

    申请日1990-10-23

  • 分类号A61K51/00;

  • 国家 DE

  • 入库时间 2022-08-21 20:29:32

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号